Orotic acid hydrate

CAS: 50887-69-9

Ref. 3D-FO46786

Información del producto

• Nombre: Orotic acid hydrate
• Sinónimos: 2,6-Dioxo-1,2,3,6-Tetrahydropyrimidine-4-Carboxylate, 2,6-Dioxo-1,2,3,6-Tetrahydropyrimidine-4-Carboxylic Acid Hydrate, 2,6-Dioxo-1,2,3,6-tetrahydro-4-pyrimidinecarboxylic acid, 2,6-Dioxo-1,2,3,6-tetrahydro-4-pyrimidinecarboxylic acid hydrate, 2.4-Dihydroxypyrimidine-6-carboxylic acid hydrate, 4-Pyrimidinecarboxylic acid, 1,2,3,6-tetrahydro-2,6-dioxo-, hydrate (1:1), 4-Pyrimidinecarboxylic acid, 1,2,3,6-tetrahydro-2,6-dioxo-, monohydrate, Orotic Acid Monohydrate

Descripción

Orotic acid hydrate is a synthetic compound that is designed to be a growth regulator. Orotic acid hydrate is synthesized by reacting the orotate with pyridoxine hydrochloride, followed by crystallizing the product. Hydrogen bonds form between the water molecules and fatty acids in the crystals of OA hydrate. These hydrogen bonds stabilize the crystal structure and allow for its use as a growth regulator. The stability of this molecule can also be attributed to its ability to form hydrogen bonds with other molecules such as α-tocopherol, calcium carbonate, and synthetic cannabinoids. Orotic acid hydrate has been shown to have an effect on cancer cells because it reacts with daunorubicin in solution and inhibits DNA synthesis, inhibiting cell growth.

• Marca: Biosynth

Propiedades químicas

• Peso molecular: 174.11 g/mol
• Fórmula: C₅H₄N₂O₄·H₂O
• Pureza: Min. 95 Area-%
• Color/Forma: Powder